RE:RE:Marketing...Their talk re creating shareholder value rings very hollow when CEO disposes of some of his shares at a time when he had left the impression of pending news re several items already well known to posters on this Board.Just like a lot of other biotecs.I sold the majority of my position in IMV a few months ago for similar reasons. Retail investors line their pockets with cash and we get mushroomed time and again. Great science but lack of performace.Hard to pull the trigger when you are already in red ink.